Azione INFANT BACTERIAL THERAPEUTICS AB (PUBL)
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati
Strumento inattivo

Altre lingue Infant Bacterial Therapeutics AB (publ) Other OTC

Azioni

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Infant Bacterial Therapeutics AB - The Connection Study, is completed
“The Connection Study” is completed
Infant Bacterial Therapeutics AB Completes Clinical Development Program
Annual General Meeting of Infant Bacterial Therapeutics
Infant Bacterial Therapeutics () : Interim report January 1 - March 31, 2024
Infant Bacterial Therapeutics AB (publ) Interim report January 1 – March 31, 2024
Infant Bacterial Therapeutics AB Reports Earnings Results for the First Quarter Ended March 31, 2024
Infant Bacterial Therapeutics : Major Milestone Achieved - Last Patient Enrolled in Infant Bacterial Therapeutics' Phase 3 Study
Major Milestone Achieved - Last Patient Enrolled in Infant Bacterial Therapeutics’ Phase 3 Study
Notice of Annual General Meeting of Infant Bacterial Therapeutics
Infant Bacterial Therapeutics AB publishes the Annual Report for 2023
Infant Bacterial Therapeutics AB (publ), Interim report January 1-December 31, 2023
Infant Bacterial Therapeutics AB Reports Earnings Results for the Full Year Ended December 31, 2023
Infant Bacterial Therapeutics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Infant Bacterial Therapeutics AB (publ), Interim report January 1-September 30, 2023
Infant Bacterial Therapeutics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Infant Bacterial Therapeutics AB (publ) announces the appointment of the Nomination Committee for the Annual General Meeting 2024
Infant Bacterial Therapeutics AB Announces the Appointment of the Nomination Committee for the Annual General Meeting 2024
Infant Bacterial Therapeutics AB (publ) Interim report January 1 - June 30, 2023
Infant Bacterial Therapeutics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione IBT B
  4. Azione
  5. Notizie Infant Bacterial Therapeutics AB (publ)
  6. Altre lingue